A randomized, double-blind, placebo-controlled, parallel

  • Caramori, Luiza (PI)

Project: Research project

Project Details

Description

A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality
StatusActive
Effective start/end date8/1/1512/31/20

Funding

  • BAYER HEALTHCARE PHARMACEUTICALS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.